Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2684 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

MedImmune initiates Phase I/IIa RSV vaccine trial

This Phase I/IIa clinical trial is designed to assess the safety, tolerability, immunogenicity and viral shedding of the intranasal respiratory syncytial virus (RSV) vaccine in infants and young

Tripos International acquires Pharsight

The transaction, valued at approximately $57 million, moves Pharsight into the Tripos portfolio. As a Tripos portfolio company, Pharsight will continue to develop and market integrated products and

Generic drugs lower US Medicare costs

The Congressional Budget Office predicted that by 2008 the US Medicare annual costs would reach $74 billion, however, the actual figure is close to $50 billion in 2008.

Pronova BioPharma names new CEO

Mr Olsen will assume the role of CEO, effective November 17, 2008. Mr Olsen joins Pronova BioPharma after 27 years with Pfizer where he gained extensive international experience